Abstract
UDP-glucuronosyltransferase (UGT) 2B7 is one of the most important UGT isozymes expressed in human livers. This enzyme is reported to show more than 10-fold interindividual differences in its enzyme activities. Thus, the amounts of UGT2B7 mRNA in 12 human livers were quantified by quantitative reverse transcription-polymerase chain reaction. The amounts of UGT2B7 mRNA in the subjects ranged from 0.22 to 2.63 copies/103 copies of β-actin. A novel point mutation (−253G to A) found in this study did not affect the level of UGT2B7 mRNA in the subjects. To clarify a causal factor(s) determining the expression level of UGT2B7 mRNA, we examined the correlation between the amounts of mRNAs for UGT2B7 and hepatocyte nuclear factor (HNF)-1α, which regulates the expression of UGT2B7gene. HNF-1α mRNA was expressed at a level ranging from 2.99 to 24.76 copies/106 copies of β-actin in the subjects. The amounts of mRNAs for UGT2B7 expressed in these individual liver samples were highly associated with the amount of mRNA for HNF-1α (r = 0.786, p = 0.002), suggesting that HNF-1α is a factor limiting the expression of UGT2B7 mRNA and a causal factor responsible for an interindividual difference in human livers.
Footnotes
-
This study was supported in part by a grant from The Organization for Pharmaceutical Safety and Research in Japan.
- Abbreviations used are::
- UGT
- UDP-glucuronosyltrasferases
- HNF
- hepatocyte nuclear factor
- RT
- reverse transcriptase
- PCR
- polymerase chain reaction
- Received January 9, 2002.
- Accepted March 6, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|